Blake Borgeson, Director: Recursion Pharmaceuticals RXRX Sell · Filed 23/03/23

Trade details

Type: Insider sale
Amount: $65,749
Shares · price: 8,885 sh · $7.40 a share
Held after: 7,576,287 sh
Stock: Recursion Pharmaceuticals RXRX
Person: Blake BorgesonDirector
Trade date: 23/03/21
Filed: 23/03/23
Days to filing: 2 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/19~23/04/20

Blake Borgeson's recent trades

Blake BorgesonDirector
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$100.2K
30,000 sh
$100.2K
Filed 09/01
Traded 09/01
Blake BorgesonDirector
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$97.5K
30,000 sh
$97.5K
Filed 08/04
Traded 08/04
Blake BorgesonDirector
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$158.5K
40,000 sh
$158.5K
Filed 07/07
Traded 07/07
Blake BorgesonDirector
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$110.4K
30,000 sh
$110.4K
Filed 06/04
Traded 06/02
Blake BorgesonDirector
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$110.4K
30,000 sh
$110.4K
Filed 06/02
Traded 06/02

Blake Borgeson, Director — sold $65.7K of Recursion Pharmaceuticals RXRX · 0.1% of holdings | Whalegun